Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease

medRxiv(2022)10.1101/2022.08.30.22279370Source: DataRank Database

Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (34)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Eric B. Dammer ORCID,Lingyan Ping ORCID,Duc M. Duong ORCID,Erica Modeste ORCID,Kathleen Carter ORCID

Live enrichment

PubMed:26207759 OpenAlex:https://openalex.org/W4294044976

National Institutes of Health

Grant: 5R01AG070937-02

The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease

National Institutes of Health

Grant: 5U01AG061357-05

AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers

National Institutes of Health

Grant: 3P30AG066511-03S2

Piloting a web-based neuropathology image resource for the ADRC community

greenLicense: cc-by

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/09/01/2022.08.30.22279370.full.pdf

GREENhttps://www.medrxiv.org/content/medrxiv/early/2022/09/01/2022.08.30.22279370.full.pdf

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/09/01/2022.08.30.22279370.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.08.30.22279370

repositoryhttps://doi.org/10.1101/2022.08.30.22279370

Fields of Study

Alzheimer's disease research and treatmentsAdvanced Proteomics Techniques and ApplicationsMetabolomics and Mass Spectrometry StudiesMedicineBiology03 medical and health sciences0302 clinical medicine

Keywords

Cerebrospinal fluidBiomarkerDementiaAsymptomaticDiseaseAlzheimer's diseaseTau proteinAmyloid βProteomicsCognitive impairmentPathologyMedicineMass spectrometryAmyloid (mycology)BiologyChemistryBiochemistryChromatographyGeneData DescriptorAlzheimer DiseaseScienceQHumansBiological AssayCerebrospinal Fluid ProteinsBiomarkers

Sustainable Development Goals

SDG 0: Good health and well-being